Literature DB >> 12085241

Gene transduction efficiency in cells of different species by HIV and EIAV vectors.

Y Ikeda1, M K L Collins, P A Radcliffe, K A Mitrophanous, Y Takeuchi.   

Abstract

The ability of human immunodeficiency virus (HIV)- and equine infectious anaemia virus (EIAV)-based vectors to transduce cell lines from a range of species was compared. Both vectors carried the vesicular stomatitis virus G (VSV-G) envelope protein and encoded an enhanced green fluorescent protein (eGFP) gene driven by a human cytomegalovirus (CMV) early promoter. Immunostaining for viral core proteins and VSV-G was used to demonstrate that the HIV and EIAV vector preparations contained similar numbers of virus particles. Various cell lines were transduced with these vectors and the transduction efficiency was estimated by measuring eGFP expression. Efficient transduction by both vectors was observed in human, hamster, pig, horse, cat and dog cell lines, although EIAV vector was about 10-fold less efficient in human, hamster and pig cells normalised to the total number of viral particles. This could be partly explained by the lower RNA genome levels per particle for EIAV as measured by real-time RT-PCR. Rodent cells appeared to be transduced inefficiently with both vectors, but when the CMV promoter was substituted with the EF1alpha promoter in the HIV vectors, the expression level increased leading to an increase in the measurable level of transduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085241     DOI: 10.1038/sj.gt.3301708

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  34 in total

1.  Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-based defective lentiviral vectors.

Authors:  Lingbing Zeng; Shiming Yang; Chengxiang Wu; Linbai Ye; Yuanan Lu
Journal:  J Virol Methods       Date:  2006-01-20       Impact factor: 2.014

2.  Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.

Authors:  Dyana T Saenz; Wulin Teo; John C Olsen; Eric M Poeschla
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.

Authors:  Sara Kathleen Powell; Ricardo Rivera-Soto; Steven James Gray
Journal:  Discov Med       Date:  2015-01       Impact factor: 2.970

4.  The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

Authors:  Teresa Faria Pais; Éva M Szegő; Oldriska Marques; Leonor Miller-Fleming; Pedro Antas; Patrícia Guerreiro; Rita Machado de Oliveira; Burcu Kasapoglu; Tiago Fleming Outeiro
Journal:  EMBO J       Date:  2013-09-06       Impact factor: 11.598

5.  Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection.

Authors:  Zhihai Si; Nick Vandegraaff; Colm O'huigin; Byeongwoon Song; Wen Yuan; Chen Xu; Michel Perron; Xing Li; Wayne A Marasco; Alan Engelman; Michael Dean; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

6.  Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.

Authors:  Barbara Mitta; Cornelia C Weber; Markus Rimann; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

7.  The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.

Authors:  Arnab Basu; Tatsuo Kanda; Aster Beyene; Kousuke Saito; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Multiple restrictions of human immunodeficiency virus type 1 in feline cells.

Authors:  Carsten Münk; Jörg Zielonka; Hannelore Constabel; Björn-Philipp Kloke; Benjamin Rengstl; Marion Battenberg; Francesca Bonci; Mauro Pistello; Martin Löchelt; Klaus Cichutek
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

Authors:  Christoph A Kahl; Jon Marsh; Joanne Fyffe; David A Sanders; Kenneth Cornetta
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.